1. Herriges, M. & Morrisey, E. E. Lung development: orchestrating the generation and regeneration of a complex organ. Development 141, 502–513 (2014).
2. Amaral, M. D., Quaresma, M. C. & Pankonien, I. What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer? Int. J. Mol. Sci. 21, (2020).
3. Morrisey, E. E. & Hogan, B. L. M. Preparing for the First Breath: Genetic and Cellular Mechanisms in Lung Development. Dev. Cell 18, 8–23 (2010).
4. Treutlein, B. et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. (2014) doi:10.1038/nature13173.
5. Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619–625 (2020).
6. Du, Y. et al. Lung Gene Expression Analysis (LGEA): an integrative web portal for comprehensive gene expression data analysis in lung development. Thorax 72, 481–484 (2017).
7. Montoro, D. T. et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 4, 19 (2018).
8. Plasschaert, L. W. et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560, 377–381 (2018).
9. He, M. et al. Chloride channels regulate differentiation and barrier functions of the mammalian airway. Elife 9, (2020).
10. Carraro, G. et al. Transcriptional analysis of cystic fibrosis airways at single-cell resolution reveals altered epithelial cell states and composition. Nat. Med. 27, 806–814 (2021).
11. Miller, A. J. et al. In Vitro and In Vivo Development of the Human Airway at Single-Cell Resolution. Dev. Cell 53, 117-128.e6 (2020).
12. Rodrigues Toste de Carvalho, A. L. et al. The in vitro multilineage differentiation and maturation of lung and airway cells from human pluripotent stem cell–derived lung progenitors in 3D. Nat. Protoc. 16, 1802–1829 (2021).
13. Hawkins, F. J. et al. Derivation of Airway Basal Stem Cells from Human Pluripotent Stem Cells. Cell Stem Cell 28, 79-95.e8 (2021).
14. McCauley, K. B. et al. Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. Cell Stem Cell 20, 844-857.e6 (2017).
15. Jacob, A. et al. Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells. Cell Stem Cell 21, 472-488.e10 (2017).
16. Takahashi, K. & Yamanaka, S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126, 663–676 (2006).
17. Takahashi, K. et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131, 861–872 (2007).
18. Wong, A. P. et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat. Biotechnol. 30, 876–882 (2012).
19. Green, M. D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–273 (2011).
20. Mou, H. et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 10, 385–397 (2012).
21. Firth, A. L. et al. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 111, (2014).
22. Wong, A. P. et al. Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat. Protoc. 10, 363–381 (2015).
23. Ahmadi, S. et al. Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia. npj Genomic Med. 2, 12 (2017).
24. Konishi, S. et al. Directed Induction of Functional Multi-ciliated Cells in Proximal Airway Epithelial Spheroids from Human Pluripotent Stem Cells. Stem Cell Reports 6, 18–25 (2016).
25. Gotoh, S. et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem cell reports 3, 394–403 (2014).
26. Huang, S. X. L. et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32, 84–91 (2014).
27. Chen, Y.-W. et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell Biol. 19, 542–549 (2017).
28. McCauley, K. B., Hawkins, F. & Kotton, D. N. Derivation of Epithelial-Only Airway Organoids from Human Pluripotent Stem Cells. Curr. Protoc. Stem Cell Biol. 45, (2018).
29. Eckford, P. D. W. et al. The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF. J. Cyst. Fibros. 18, 35–43 (2019).
30. Berkers, G. et al. Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis. Cell Rep. 26, 1701-1708.e3 (2019).
31. Nikolic, M. Z. et al. Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as long-term self-renewing organoids. (2017) doi:10.7554/eLife.26575.001.
32. Marcorelles, P., Montier, T., Gillet, D., Lagarde, N. & Ferec, C. Evolution of CFTR protein distribution in lung tissue from normal and CF human fetuses. Pediatr. Pulmonol. 42, 1032–1040 (2007).
33. Ruiz García, S. et al. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 146, (2019).
34. Sunday, M. E. Pulmonary neuroendocrine cells and lung development. Endocr. Pathol. 7, 173–201 (1996).
35. Aros, C. J., Pantoja, C. J. & Gomperts, B. N. Wnt signaling in lung development, regeneration, and disease progression. Commun. Biol. 4, 601 (2021).
36. Hawkins, F. et al. Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells. J. Clin. Invest. 127, 2277–2294 (2017).
37. Jiang, J. X. et al. A new platform for high-throughput therapy testing on iPSC-derived , immature airway from Cystic Fibrosis Patients. bioRxiv 1–22 (2021) doi:10.1101/2021.07.05.451013.
38. Xia, S. et al. High-throughput functional analysis of CFTR and other apically localized channels in iPSC derived intestinal organoids. bioRxiv (2021).
39. Tizzano, E. F., O’Brodovich, H., Chitayat, D., Bènichou, J. C. & Buchwald, M. Regional expression of CFTR in developing human respiratory tissues. Am. J. Respir. Cell Mol. Biol. 10, 355–362 (1994).
40. Boj, S. F. et al. Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients. J. Vis. Exp. (2017) doi:10.3791/55159.
41. Schittny, J. C. Development of the lung. Cell Tissue Res. 367, 427–444 (2017).
42. Tsukui, T. et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat. Commun. 11, 1920 (2020).
43. Zhou, Y. et al. Extracellular matrix in lung development, homeostasis and disease. Matrix Biol. 73, 77–104 (2018).
44. Curtis, J. L. Cell-mediated adaptive immune defense of the lungs. Proc. Am. Thorac. Soc. 2, 412–6 (2005).
45. Kaiser, F., Huebecker, M. & Wachten, D. Sphingolipids controlling ciliary and microvillar function. FEBS Lett. 594, 3652–3667 (2020).
46. Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496–502 (2019).
47. Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888-1902.e21 (2019).
48. Wolf, F. A. et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol. 20, 59 (2019).
49. Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).
50. Mcginnis, C. S. et al. MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices. doi:10.1038/s41592-019-0433-8.
51. Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
52. Soneson, C. & Robinson, M. D. Bias, robustness and scalability in single-cell differential expression analysis. Nat. Publ. Gr. 15, (2018).
53. Hurley, K. et al. Reconstructed Single-Cell Fate Trajectories Define Lineage Plasticity Windows during Differentiation of Human PSC-Derived Distal Lung Progenitors. Cell Stem Cell 26, 593-608.e8 (2020).
54. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
55. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
56. Laselva, O. et al. Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants. J. Cyst. Fibros. 20, 106–119 (2021).
57. Metzger, R. J., Klein, O. D., Martin, G. R. & Krasnow, M. A. The branching programme of mouse lung development. Nature 453, 745–750 (2008).
58. Lavelle, G. M., White, M. M., Browne, N., McElvaney, N. G. & Reeves, E. P. Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences. Biomed Res. Int. 2016, 5258727 (2016).
59. Miller, A. J. et al. In Vitro Induction and In Vivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells. Stem Cell Reports 10, 101–119 (2018).
60. Qian, X. et al. Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure. Cell 165, 1238–1254 (2016).
61. Garcez, P. P. et al. Zika virus impairs growth in human neurospheres and brain organoids. Science (80-. ). 352, 816–818 (2016).
62. Sampaziotis, F. et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat. Biotechnol. 33, 845–852 (2015).
63. Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225–230 (2011).
64. Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. doi:10.1038/nature12517.
65. Taylor, B., Rice, A., Nicholson, A. G., Hind, M. & Dean, C. H. Mechanism of lung development in the aetiology of adult congenital pulmonary airway malformations. Thorax 75, 1001–1003 (2020).
66. Khan, T. Z. et al. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 1075–82 (1995).
67. Ornoy, A. et al. Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am. J. Med. Genet. 28, 935–47 (1987).
68. Tepper, R. S. et al. Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr. Pulmonol. 5, 15–8 (1988).
69. Ackerman, V., Montogomery, G., Eigen, H. & Tepper, R. S. Assessment of airway responsiveness in infants with cystic fibrosis. Am. Rev. Respir. Dis. 144, 344–6 (1991).
70. Beardsmore, C. S. et al. Lung function in infants with cystic fibrosis. Thorax 43, 545–51 (1988).
71. Verhaeghe, C., Tabruyn, S. P., Oury, C., Bours, V. & Griffioen, A. W. Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. Biochem. Biophys. Res. Commun. 356, 745–9 (2007).
72. Fleischer, A. et al. iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation. Mol. Ther. - Methods Clin. Dev. 17, 858–870 (2020).
73. Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
74. Nikolić, M. Z., Sun, D. & Rawlins, E. L. Human lung development: Recent progress and new challenges. Dev. 145, (2018).
75. Li, J. et al. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer. Int. J. Oncol. 46, 2107–15 (2015).
76. Mou, H. et al. Airway basal stem cells generate distinct subpopulations of PNECs. Cell Rep. 35, 109011 (2021).